DATE: October 01, 2015
Who is Our Client?
- National Enzyme Company is the leading global contract manufacturer of enzyme-based vitamin, mineral and supplement (VMS) products serving the health & wellness marketplace.
- In addition to its contract manufacturing offering, National Enzyme Company operates two-wholly owned subsidiaries: SORA Laboratories and American Animal Nutrition.
- SORA Laboratories is an ISO 9001 and ISO 17025 certified laboratory providing full-service analytical, microbiological, and physical testing services to the VMS, industrial and food industries. SORA maintains FDA cGMP compliance for the VMS industry.
- American Animal Nutrition provides customized vitamin, mineral and supplement solutions to the animal health market segment.
- Founded in 1945, National Enzyme Company employs 140 people in the Branson, Missouri area.
Why Did National Enzyme Company Hire Nolan?
- National Enzyme Company’s founder sought a sale for estate planning purposes and to secure an exit partner that would continue the company’s legacy from a product, operational and cultural perspective.
- National Enzyme Company, along with its subsidiaries, represented a unique opportunity for a buyer to invest in the global leader in enzyme-based VMS solutions.
What Value Did Nolan Deliver?
- Nolan marketed National Enzyme Company’s best-in-class enzyme expertise, one-stop shop production, extensive product portfolio and broad services as an attractive acquisition or investment opportunity.
- Included in the list of potential buyers and investors was Prairie Capital, a Chicago-based private equity firm that has invested over $800 MM over five funds in middle market businesses since the firm’s founding in 1997.
- Prairie was included in the National Enzyme Company sale process because of their activity in the VMS industry and reputation as a high quality, Midwestern investor with a proven track record.
- Prairie presented National Enzyme Company’s stockholders with the best acquisition proposal which included a combination of favorable economics, certainty to close and operational/cultural considerations.
